FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004183309> ?p ?o ?g. }

• W2004183309 endingPage "224" @default.
• W2004183309 startingPage "217" @default.
• W2004183309 abstract "HomeCirculationVol. 79, No. 2Plasminogen activators. The old and the new. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBPlasminogen activators. The old and the new. M S Runge, T Quertermous and E Haber M S RungeM S Runge Cardiac Unit, Massachusetts General Hospital, Boston 02114. Search for more papers by this author , T QuertermousT Quertermous Cardiac Unit, Massachusetts General Hospital, Boston 02114. Search for more papers by this author and E HaberE Haber Cardiac Unit, Massachusetts General Hospital, Boston 02114. Search for more papers by this author Originally published1 Feb 1989https://doi.org/10.1161/01.CIR.79.2.217Circulation. 1989;79:217–224 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Bi Z, Wang Y and Zhang W (2021) A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment, Biomedicine & Pharmacotherapy, 10.1016/j.biopha.2021.111404, 137, (111404), Online publication date: 1-May-2021. Yue Y, Yan S, Li H, Zong Y, Yue J and Zeng L (2018) The role of oral fluvastatin on postoperative peritoneal adhesion formation in an experimental rat model, Acta Chirurgica Belgica, 10.1080/00015458.2018.1444549, 118:6, (372-379), Online publication date: 2-Nov-2018. Clements M and Bonnecaze R (2013) Diffusion Limited Delivery of Streptokinase and tPA to a Thrombus, Cardiovascular Engineering and Technology, 10.1007/s13239-013-0160-8, 4:4, (364-373), Online publication date: 1-Dec-2013. Hellebrekers B and Kooistra T (2011) Pathogenesis of postoperative adhesion formation, British Journal of Surgery, 10.1002/bjs.7657, 98:11, (1503-1516), Online publication date: 3-Oct-2011. Molinas C, Elkelani O, Campo R, Luttun A, Carmeliet P and Koninckx P (2003) Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum–enhanced adhesion formation after laparoscopic surgery in transgenic mice, Fertility and Sterility, 10.1016/S0015-0282(03)00496-5, 80:1, (184-192), Online publication date: 1-Jul-2003. Santos de Soto J, Menéndez González N, Soult Rubio J, Grueso Montero J, López Castilla J and Descalzo Señorans A (2001) Tratamiento fibrinolítico con activador tisular de plasminógeno de una fístula modificada de Blalock-Taussig trombosada, Revista Española de Cardiología, 10.1016/S0300-8932(01)76460-3, 54:9, (1113-1115), Online publication date: 1-Jan-2001. Thompson J (2000) Peritoneal Fibrinolysis and Adhesion Formation Peritoneal Surgery, 10.1007/978-1-4612-1194-5_9, (133-142), . Sugimachi K, Yonemitsu Y, Komori K and Sugimachi K (2016) Conservative Treatment for the Removal of a Central Venous Catheter with Large Thrombus: A Case Report, Nutrition in Clinical Practice, 10.1177/088453360001500504, 15:5, (223-226), Online publication date: 1-Oct-2000. Kurnik P (1996) PRACTICAL IMPLICATIONS OF CIRCADIAN VARIATIONS IN THROMBOLYTIC AND ANTITHROMBOTIC ACTIVITIES, Cardiology Clinics, 10.1016/S0733-8651(05)70278-2, 14:2, (251-262), Online publication date: 1-May-1996. MAKSIMENKO A, TISCHENKO E, PETROV A and PETROVA M (1996) Effective Enzyme Thrombolytic Composition on the Basis of Wild-type and Chemically Modified Plasminogen Activators, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1996.tb33191.x, 799:1 Enzyme Engine, (146-150), Online publication date: 1-Oct-1996. Maksimenko A, Tishchenko E, Petrova M and Golubykh V (1996) Potentiation and acceleration effects in combined administration of tissue plasminogen activator and fibrinogen-modified urokinase in dogs with modeled venous thrombosis, Bulletin of Experimental Biology and Medicine, 10.1007/BF02445703, 121:1, (44-47), Online publication date: 1-Jan-1996. Maksimenko A, Tischenko E, Petrov A, Petrova M and Golubykh V (1996) Venous thrombolysis by tissue-type plasminogen activator in conjunction with the urokinase-fibrinogen covalent conjugate, Applied Biochemistry and Biotechnology, 10.1007/BF02785694, 61:1-2, (123-128), Online publication date: 1-Oct-1996. Yamada Y and Yokota M (1996) Direct Interactions of Plasminogen Activators with Human Aortic and Pulmonary Artery Endothelial Cells In Vitro: Implications for Thrombolytic Therapy, Journal of Cardiovascular Pharmacology, 10.1097/00005344-199605000-00003, 27:5, (629-635), Online publication date: 1-May-1996. Maksimenko A (1994) Mutant and hybrid protein derivatives for the experimental therapy with plasminogen activators (review), Pharmaceutical Chemistry Journal, 10.1007/BF02218422, 28:5, (293-302), Online publication date: 1-May-1994. Ries M, Singer H and Hofbeck M (1994) Thrombolysis of a modified Blalock-Taussig shunt with recombinant tissue plasminogen activator in a newborn infant with pulmonary atresia and ventricular septal defect., Heart, 10.1136/hrt.72.2.201, 72:2, (201-202), Online publication date: 1-Aug-1994. Arnljots B, Dougan P, Salemark L and Bergquvist D (2009) Effects of Streptokinase and Urokinase on Microarterial Thrombosis and Haemostasis: An experimental study in rabbits , Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 10.3109/02844319409015988, 28:1, (9-13), Online publication date: 1-Jan-1994. Maksimenko A (1994) Experimental combined thrombolytic therapy: The current position and directions of progress (review), Pharmaceutical Chemistry Journal, 10.1007/BF02219399, 28:12, (867-878), Online publication date: 1-Dec-1994. Rodenhuis S, van't Hek L, Vlasveld L, Kroger R, Dubbelman R and van Tol R (1993) Central venous catheter associated thrombosis of major veins: thrombolytic treatment with recombinant tissue plasminogen activator., Thorax, 10.1136/thx.48.5.558, 48:5, (558-559), Online publication date: 1-May-1993. Shi G, Hau J, Wang S, Wu I, Chang B, Lin M, Chow Y, Chang W, Wing L and Jen C (1992) Plasmin and the regulation of tissue-type plasminogen activator biosynthesis in human endothelial cells., Journal of Biological Chemistry, 10.1016/S0021-9258(18)41783-8, 267:27, (19363-19368), Online publication date: 1-Sep-1992. Tsumoto S, Kawashima S, Ueno M, Morita M, Kondo T and Iwasaki T (1992) Effects of Calcitonin Gene-Related Peptide on Systemic and Regional Hemodynamics in Dogs with Congestive Heart Failure New Aspects in the Treatment of Failing Heart, 10.1007/978-4-431-68219-6_36, (183-185), . Egashira K, Kawai K, Nagano M, Sakuma A, Nakamura M and Tomoike H (1992) Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs, Journal of the American College of Cardiology, 10.1016/0735-1097(92)90162-G, 20:1, (218-225), Online publication date: 1-Jul-1992. Fukao H, Ueshima S, Okada K, Yamamoto K, Matsuo T and Matsuo O (1992) Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation, Thrombosis Research, 10.1016/0049-3848(92)90127-V, 68:1, (57-65), Online publication date: 1-Oct-1992. STEPHENS C (1991) The antiphospholipid syndrome. Clinical correlations, cutaneous features, mechanism of thrombosis and treatment of patients with the lupus anticoagulant and anticardiolipin antibodies, British Journal of Dermatology, 10.1111/j.1365-2133.1991.tb14741.x, 125:3, (199-210), Online publication date: 1-Sep-1991. Rutherford S and Phelan J (1991) Deep Venous Thrombosis and Pulmonary Embolism in Pregnancy, Obstetrics and Gynecology Clinics of North America, 10.1016/S0889-8545(21)00277-1, 18:2, (345-370), Online publication date: 1-Jun-1991. Krogmann O, v. Kries R, Rammos S, Kramer H and Bourgeois M (1991) Left ventricular thrombus in a 2-year-old boy with cardiomyopathy: Lysis with recombinant tissue-type plasminogen activator, European Journal of Pediatrics, 10.1007/BF01955000, 150:12, (829-831), Online publication date: 1-Oct-1991. Yamada Y, Furui H, Furumichi T, Yamauchi K, Yokota M and Saito H (1991) Possible mechanism of vascular reocclusion after initially successful thrombolysis with recombinant tissue-type plasminogen activator, American Heart Journal, 10.1016/0002-8703(91)90004-2, 121:6, (1618-1627), Online publication date: 1-Jun-1991. Adams D, Griffin L, Nachajko W, Reddy V and Wei C (1991) A synthetic DNA encoding a modified human urokinase resistant to inhibition by serum plasminogen activator inhibitor, Journal of Biological Chemistry, 10.1016/S0021-9258(18)92999-6, 266:13, (8476-8482), Online publication date: 1-May-1991. Flier J, Underhill L and Coller B (1990) Platelets and Thrombolytic Therapy, New England Journal of Medicine, 10.1056/NEJM199001043220107, 322:1, (33-42), Online publication date: 4-Jan-1990. Krichbaum D and Trivedi D (2016) Thrombolytic Therapy in Acute Myocardial Infarction, Journal of Pharmacy Practice, 10.1177/089719009000300507, 3:5, (332-348), Online publication date: 1-Oct-1990. Smith L and Coltart D (1990) Cardiology., Postgraduate Medical Journal, 10.1136/pgmj.66.774.263, 66:774, (263-279), Online publication date: 1-Apr-1990. Barclay G, Allen K and Pennington C (1990) Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition., Postgraduate Medical Journal, 10.1136/pgmj.66.775.398, 66:775, (398-400), Online publication date: 1-May-1990. Samlaska C and James W (1990) Superficial thrombophlebitis I. Primary hypercoagulable states, Journal of the American Academy of Dermatology, 10.1016/0190-9622(90)70139-9, 22:6, (975-989), Online publication date: 1-Jun-1990. White C (1989) Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy., Circulation, 80:5, (1482-1485), Online publication date: 1-Nov-1989. February 1, 1989Vol 79, Issue 2 Advertisement Article InformationMetrics Copyright © 1989 by American Heart Associationhttps://doi.org/10.1161/01.CIR.79.2.217 Originally publishedFebruary 1, 1989 PDF download Advertisement" @default.
• W2004183309 created "2016-06-24" @default.
• W2004183309 creator A5051232840 @default.
• W2004183309 creator A5080657847 @default.
• W2004183309 creator A5086729202 @default.
• W2004183309 date "1989-02-01" @default.
• W2004183309 modified "2023-09-27" @default.
• W2004183309 title "Plasminogen activators. The old and the new." @default.
• W2004183309 cites W1492272638 @default.
• W2004183309 cites W1495467917 @default.
• W2004183309 cites W1517933273 @default.
• W2004183309 cites W1525904017 @default.
• W2004183309 cites W1537376484 @default.
• W2004183309 cites W1539803033 @default.
• W2004183309 cites W1574505897 @default.
• W2004183309 cites W168812830 @default.
• W2004183309 cites W1989078236 @default.
• W2004183309 cites W1994207065 @default.
• W2004183309 cites W2000276981 @default.
• W2004183309 cites W2004414131 @default.
• W2004183309 cites W201040848 @default.
• W2004183309 cites W2028205094 @default.
• W2004183309 cites W2032364607 @default.
• W2004183309 cites W2036004307 @default.
• W2004183309 cites W2038431234 @default.
• W2004183309 cites W2040551353 @default.
• W2004183309 cites W2045905507 @default.
• W2004183309 cites W2046903335 @default.
• W2004183309 cites W2055725056 @default.
• W2004183309 cites W2057209113 @default.
• W2004183309 cites W2062005186 @default.
• W2004183309 cites W2062957366 @default.
• W2004183309 cites W2064242031 @default.
• W2004183309 cites W2064580781 @default.
• W2004183309 cites W2076407505 @default.
• W2004183309 cites W2082305734 @default.
• W2004183309 cites W2085869089 @default.
• W2004183309 cites W2087480868 @default.
• W2004183309 cites W2089237765 @default.
• W2004183309 cites W2090993415 @default.
• W2004183309 cites W2093923223 @default.
• W2004183309 cites W2100410983 @default.
• W2004183309 cites W2115385634 @default.
• W2004183309 cites W2138877156 @default.
• W2004183309 cites W2336300147 @default.
• W2004183309 cites W2395871307 @default.
• W2004183309 cites W2417375021 @default.
• W2004183309 cites W2462282265 @default.
• W2004183309 cites W2525054883 @default.
• W2004183309 cites W5358143 @default.
• W2004183309 doi "https://doi.org/10.1161/01.cir.79.2.217" @default.
• W2004183309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2644053" @default.
• W2004183309 hasPublicationYear "1989" @default.
• W2004183309 type Work @default.
• W2004183309 sameAs 2004183309 @default.
• W2004183309 citedByCount "39" @default.
• W2004183309 countsByYear W20041833092013 @default.
• W2004183309 countsByYear W20041833092018 @default.
• W2004183309 countsByYear W20041833092021 @default.
• W2004183309 countsByYear W20041833092023 @default.
• W2004183309 crossrefType "journal-article" @default.
• W2004183309 hasAuthorship W2004183309A5051232840 @default.
• W2004183309 hasAuthorship W2004183309A5080657847 @default.
• W2004183309 hasAuthorship W2004183309A5086729202 @default.
• W2004183309 hasBestOaLocation W20041833091 @default.
• W2004183309 hasConcept C126322002 @default.
• W2004183309 hasConcept C164705383 @default.
• W2004183309 hasConcept C71924100 @default.
• W2004183309 hasConceptScore W2004183309C126322002 @default.
• W2004183309 hasConceptScore W2004183309C164705383 @default.
• W2004183309 hasConceptScore W2004183309C71924100 @default.
• W2004183309 hasIssue "2" @default.
• W2004183309 hasLocation W20041833091 @default.
• W2004183309 hasLocation W20041833092 @default.
• W2004183309 hasOpenAccess W2004183309 @default.
• W2004183309 hasPrimaryLocation W20041833091 @default.
• W2004183309 hasRelatedWork W1531601525 @default.
• W2004183309 hasRelatedWork W2748952813 @default.
• W2004183309 hasRelatedWork W2758277628 @default.
• W2004183309 hasRelatedWork W2899084033 @default.
• W2004183309 hasRelatedWork W2935909890 @default.
• W2004183309 hasRelatedWork W2948807893 @default.
• W2004183309 hasRelatedWork W3173606202 @default.
• W2004183309 hasRelatedWork W3183948672 @default.
• W2004183309 hasRelatedWork W2778153218 @default.
• W2004183309 hasRelatedWork W3110381201 @default.
• W2004183309 hasVolume "79" @default.
• W2004183309 isParatext "false" @default.
• W2004183309 isRetracted "false" @default.
• W2004183309 magId "2004183309" @default.
• W2004183309 workType "article" @default.